Innovative Sensor Technology Sibel Health develops soft, flexible sensors powered by advanced analytics, making them highly suitable for hospitals, clinics, and home care providers seeking non-invasive, reliable patient monitoring solutions.

Strong Funding Backing With recent Series C funding of 30 million dollars from investors such as the Steele Foundation for Hope and Dräger, Sibel Health has substantial capital to expand its product portfolio and scale sales efforts in healthcare markets.

Diverse Market Engagement The company's focus spans neonatal, maternal, and adult patient monitoring as well as clinical trial platforms, offering multiple entry points for sales targeting hospitals, clinical research organizations, and telehealth services.

Global Expansion Potential Partnerships like the collaboration with Maruho and grants from organizations like the Bill & Melinda Gates Foundation demonstrate opportunities for entering emerging markets and low-resource regions with tailored health tech products.

Regulatory and Clinical Validation Recent FDA clearances and partnerships with Medidata Solutions position Sibel Health as a trusted, compliant provider, easing the sales process in healthcare institutions prioritizing regulatory-approved digital health solutions.